Characteristics of Patients Losing Vision after 2 Years of Monthly Dosing in the Phase III Ranibizumab Clinical Trials

Title
Characteristics of Patients Losing Vision after 2 Years of Monthly Dosing in the Phase III Ranibizumab Clinical Trials
Authors
Keywords
-
Journal
OPHTHALMOLOGY
Volume 118, Issue 3, Pages 523-530
Publisher
Elsevier BV
Online
2010-10-04
DOI
10.1016/j.ophtha.2010.07.011

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now